Telix Pharmaceuticals Limited announces highly positive top-line results from the pivotal Phase III ZIRCON study (Zirconium in Renal Cancer Oncology, NCT03849118) of its investigational...
VivaVision Biotech, Inc., an ophthalmic pharmaceutical developer focusing on discovery and development of innovative therapies for ocular diseases, announced positive topline results from a...
